About nctacancer

This author has not yet filled in any details.
So far nctacancer has created 16 blog entries.

Best Practices When Choosing Tissue or Liquid Biopsy Specimens for Biomarker Testing in Breast Cancer Webinar

Register and Save the Date for October 16, 2025, 2:00 PM. This 30-minute educational webinar is designed for health care providers and stakeholders seeking to optimize biomarker testing strategies in breast cancer within the community oncology setting. The session provides a comprehensive overview of when and how to utilize tissue and/or liquid biopsy specimens across the breast cancer care continuum.

National Cancer Treatment Alliance 2023/2024 Public Benefit Report

Pursuant to the charter of the National Cancer Treatment Alliance (NCTA), and in accordance with applicable state laws, we present the 2023/2024 NCTA Public Benefit Report. This report seeks to capture our promotion of the public benefit specified in the NCTA charter and the interests of those affected by our activities.

National Cancer Treatment Alliance Adds Kiana Mehring, MBA, as Board Member

The National Cancer Treatment Alliance (NCTA), a national network of independent community oncology practices that works with employers to ensure their employees have access to high-quality, high-value, and local cancer care, announced today that Kiana Mehring, MBA, of Florida Cancer Specialists and Research Institute (FCS), has joined the NCTA Board of Directors.

National Cancer Treatment Alliance Appoints Two New Board Members

The National Cancer Treatment Alliance (NCTA), a nationwide network of leading, independent community oncology practices that have joined together to help employers improve cancer care, announced today the appointment of two new board members, Mark Nelson, PharmD, Chief Executive Officer at Northwest Medical Specialties and Travis Brewer, Vice President of Payer and Public Health Strategy/Relations at Texas Oncology.

Go to Top